Pars Journal of Medical Sciences

Effect of citric acid on p53 and p21 genes expression of the human gastric Adenocarcinoma cell line (AGS)

Authors

1 Department of Genetic, Shahrekord Branch, University of Islamic Azad, Shahrekord, Iran

2 Department of Physiology, Shahrekord Branch, University of Islamic Azad, Shahrekord, Iran

3 Department of Biochemistry, Shahrekord Branch, University of Islamic Azad, Shahrekord, Iran

4 Department of Genetics, School of Medicine, University of Islamic Azad, Kazerun, Iran

Abstract

Introduction: Gastric adenocarcinoma is the second leading cause of death from cancer worldwide. Citric acid is a naturally organic acid that considered as a physiological inhibitor of enzymes involved in glycolysis pathway to remove cancer cells. In this study, the effect of citric acid on p53 and p21 genes expression of the human gastric adenocarcinoma cell line (AGS) was examined.
Materials and Methods: AGS cells with different concentrations of citric acid (400, 800 and 1600 μg / ml) to examine the
expression of genes P53 and p21 were incubated for 24 and 48 hours. Then, the expression of p53 and p21 genes were analyzed by Real Time PCR.
Results: The results of this study indicate that treatment with citric acid increased the expression of p53 and p21 genes in the experimental groups compared to the control group. Over expression of p53 gene at concentrations of 1600 and 800 μg / ml, respectively, was significant at 24 and 48 hours incubation times in dose and time independent manner. Expression of p21 gene at both incubation times was dose-and time dependent manner.
Conclusion: The results indicate that citric acid can reduce the growth of gastric adenocarcinoma cells by inducing
expression of genes that involved in the apoptosis pathway and preventing proliferation. Therefore, citric acid seems to be used as an anticancer agent for the treatment of gastric cancer.

Keywords

[1] Imanipour M. (2009). Principles of oncology nursing. Tehran, Tohfe & Boshra, Second ed [Persian] [2] Farazmandfar T, Janbabaei G, Azadeh H. (2011). Common on aspects of cancer. Sari, MazandaranUniversity of Medical Sciences, 1st ed [Persian] [3] Hoda S, Aliee A, and Shakiba M. (2003). A study offrequency of cancerous organs in Guilanprovince (1999-2000). J Med Fac Guilan UniMed Sci 12: 84-92. [4] Harrison, Fauci, and Braunwald. (1998). principle of internalmedicine. New York, McGraw Hill, 14th ed, 1610-1612. [5] Broecker-Preuss M, Viehof J, and Jastrow H. (2015). Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells. Journal of Experimental & Clinical Cancer Research 34(1): 15-186. [6] Broecker-Preuss M, Becher-Boveleth N, and Müller S. (2016). The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells. Cancer cell international 16(1): 303-8. [7] Xue X, Yu J-L, Sun D-Q. Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways. APJCP 2013; 15(9): 3987-3992. [8] Broecker-Preuss M, Viehof J, Jastrow H. Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells. Journal of Experimental & Clinical Cancer Research 2015; 34(1): 15-186. [9] Zhu L, Li L, and Li Y. (2016). Chinese Herbal Medicine as an Adjunctive Therapy for Breast Cancer. Evid.comp.alter.med doi: 10.1155/2016/9469276. [10] Angumeena AR, Venkappayya D. (2013). An overview of citric acid production. LWT-Food Sci Technol 50(2): 367-370. [11] Zhang XD, Varin E, and Icard P. (2009). Effect of citrate on malignantpleural mesothelioma cells: a synergistic effect with cisplatin. Anticancer Res 29: 1249-1254. [12] Pedersen PL, Mathupala S, and Rempel A. (2002). Mitochondrialbound type II hexokinase: a key player in the growth andsurvival of many cancers and an ideal prospect for therapeuticintervention. Biochim Biophys Acta 1555: 14-20. [13] Pastorino JG, Hoek JB. (2008). Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr 40: 171-82. [14] Matoba Satoaki. (2006). p53 regulates mitochondrial respiration. Science 312(5780): 1650-1653. [15] Lu Y, Zhang X, Zhang H. Citrate induces apoptotic cell death: a promising way to treat gastric carcinoma?. Anticancer research 2011; 31(3): 797-805. [16] Ying TH, Chen CW, Hsiao YP. Citric acid induces cell-cycle arrest and apoptosis of human immortalized keratinocyte cell line (HaCaT) via caspase-and mitochondrial-dependent signaling pathways. Anticancer research 2013; 33(10): 4411-20. [17] Ren JG, Seth P, and Ye H. Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway. Scientific reports 2017; 7(1): 4537.